NCT00373841 Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF) Status RECRUITING Phase N/A
NCT00287729 Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE3
NCT00287716 Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE3
NCT00262405 Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT00212511 Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry Status WITHDRAWN Phase N/A
NCT00203697 Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study Status UNKNOWN Phase PHASE3
NCT00189176 Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT00125385 Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE1
NCT00105183 EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection Status COMPLETED Phase PHASE3
NCT00080223 Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT00076635 An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF Status TERMINATED Phase PHASE3
NCT00075998 The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) Status TERMINATED Phase PHASE3
NCT00074698 Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE1
NCT00071461 Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2/PHASE3
NCT00047658 A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT00047645 A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE3